Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 11/20 | 0.50 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | ABCC1 | P33527 | 8/20 | 0.45 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6225496 | 0.82 | CRHBP (0.54) | ABCB1CRHBPCRHR2ABCC1KCNMA1 | |
| SCHEMBL27502700 | 0.82 | ABCB1 (0.53) | ABCB1CRHBPCRHR2ABCC1KCNMA1 | |
| SCHEMBL4221601 | 0.79 | ABCB1 (0.52) | ABCB1CRHBPCRHR2ABCC1KCNMA1 | |
| SCHEMBL2273770 | 0.78 | ELANE (0.46) | ABCB1CRHBPCRHR2KCNMA1TSHR | |
| SCHEMBL13890931 | 0.77 | ALOX5 (0.43) | ABCB1KCNMA1TSHRMEN1KMT2A | |
| SCHEMBL5517515 | 0.77 | GRIN2D (0.43) | CRHBPCRHR2POLBHTTALDH1A1 | |
| SCHEMBL5897546 | 0.76 | ESR1 (0.38) | POLBHTTALDH1A1CYP3A4TSHR | |
| SCHEMBL8365480 | 0.76 | ABCB1 (0.49) | ABCB1CRHBPCRHR2ABCC1KCNMA1 | |
| SCHEMBL7562427 | 0.76 | ALDH1A1 (0.61) | ABCB1CRHBPCRHR2ABCC1HTT | |
| SCHEMBL3236492 | 0.76 | ABCB1 (0.60) | ABCB1ABCC1KCNMA1HTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6866980-B2 | Bis-o-aminophenol derivatives, poly-o-hydroxyamides, and polybenzoxazoles, usable in photosensitive compositions, dielectrics, buffer coatings, and microelectronics | INFINEON TECHNOLOGIES AG (DE) | 2005-03-15 | — | — | US | disclosed |
| US-20030104311-A1 | Bis-o-aminophenol derivatives, poly-o-hydroxyamides, and polybenzoxazoles, usable in photosensitive compositions, dielectrics, buffer coatings, and microelectronics | POLARIS INNOVATIONS LIMITED (IE) | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104311-A1 | Bis-o-aminophenol derivatives, poly-o-hydroxyamides, and polybenzoxazoles, usable in photosensitive compositions, dielectrics, buffer coatings, and microelectronics | TET1, TET3, TET2 | ABCB1 1494/4885CRHBP 1766/4885CRHR2 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.